Alexandra Yakusheva: ThrombInnov Debuts at ISTH 2026 with a Focus on Translational Research
Alexandra Yakusheva, Preclinical Scientist at EFS, shared a post on LinkedIn:
“Excited to share something I’ve been working on over the past months.
Together with an amazing team, we have founded ThrombInnov, a CRO dedicated to thrombosis and haemostasis research, with the goal of making advanced preclinical models more accessible to academia and industry.
I’m proud to be one of the co-founders of this project and excited to contribute to building it from the ground up.
Today is also the first day of ISTH 2026, where Pierre Mangin and I will be representing ThrombInnov.
If you’re attending the congress and would like to discuss preclinical thrombosis models, collaborations or simply say hello, we’d be delighted to meet you.”
Stay updated with Hemostasis Today.
-
Jul 12, 2026, 08:2210 Posts Not To Miss from ISTH 2026, Part 1
-
Jul 12, 2026, 07:58Brian O Mahony: Could NXT-007 Minimize the Need for Perioperative FVIII
-
Jul 12, 2026, 07:50Shayan Mohammadmoradi: Connecting the Next Generation of Hemostasis Researchers at ISTH 2026
-
Jul 12, 2026, 07:34Wolfgang Miesbach: ISTH 2026 Explores the Next Generation of APS Diagnostics
-
Jul 12, 2026, 07:28Sara Zalghout: ISTH 2026 Highlights Progress in Thromboinflammation Research
-
Jul 12, 2026, 07:13Ekaterina Balaian: Finding Healing Through Art at ISTH 2026
-
Jul 12, 2026, 06:59Maaike Sybil Jongen: Flow Cytometry for Platelet Phenotyping at ISTH 2026
-
Jul 12, 2026, 06:45Brian O Mahony: Advancing Concizumab Therapy for Hemophilia With Inhibitors at ISTH 2026
-
Jul 12, 2026, 06:42PERT-Guided Patient Selection for Advanced Pulmonary Embolism Therapies